Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.
Department of Health Metrics Sciences, School of Medicine, University of Washington, Seattle, WA, USA.
Nat Med. 2022 Oct;28(10):2019-2026. doi: 10.1038/s41591-022-01990-1. Epub 2022 Oct 10.
The Global Burden of Disease Study (GBD) began 30 years ago with the goal of providing timely, valid and relevant assessments of critical health outcomes. Over this period, the GBD has become progressively more granular. The latest iteration provides assessments of thousands of outcomes for diseases, injuries and risk factors in more than 200 countries and territories and at the subnational level in more than 20 countries. The GBD is now produced by an active collaboration of over 8,000 scientists and analysts from more than 150 countries. With each GBD iteration, the data, data processing and methods used for data synthesis have evolved, with the goal of enhancing transparency and comparability of measurements and communicating various sources of uncertainty. The GBD has many limitations, but it remains a dynamic, iterative and rigorous attempt to provide meaningful health measurement to a wide range of stakeholders.
全球疾病负担研究（GBD）于 30 年前启动，其目标是及时、有效地提供有关关键健康结果的相关评估。在此期间，GBD 的研究内容逐渐变得更加详细。最新的研究提供了 200 多个国家和地区以及 20 多个国家的疾病、伤害和风险因素的数千种结果的评估。GBD 现在由来自 150 多个国家的 8000 多名科学家和分析师组成的积极合作关系共同完成。随着每次 GBD 迭代，用于数据综合的数据、数据处理和方法都在不断发展，其目标是提高测量的透明度和可比性，并传达各种不确定性来源。GBD 有许多局限性，但它仍然是一个动态的、迭代的和严格的尝试，旨在为广泛的利益相关者提供有意义的健康衡量标准。
